成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 1611493-60-7 Chemical Structure| 1611493-60-7
Chemical Structure| 1611493-60-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 1611493-60-7

,{[proInfo.pro_purity]}

Bictegravir is a potent, unboosted, once-Daily HIV-1 Integrase Strand Transfer inhibitor (INSTI) (IC50 - 1.6 nM) with improved pharmacokinetics and in vitro resistance profile.

Synonyms: Bictegravir

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Bictegravir

CAS No. :1611493-60-7
Formula : C21H18F3N3O5
M.W : 449.38
SMILES Code : O=C(C1=CN(C2=C(O)C1=O)C[C@@]3([H])O[C@](C4)([H])CC[C@]4([H])N3C2=O)NCC5=C(F)C=C(F)C=C5F
Synonyms :
Bictegravir
MDL No. :MFCD31536971
InChI Key :SOLUWJRYJLAZCX-LYOVBCGYSA-N
Pubchem ID :90311989

Safety of Bictegravir

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02400307 HIV PHASE1 COMPLETED 2015-07-13 Avail Clinical Research, DeLan... More >>d, Florida, 32720, United States|Clinical Pharmacology of Miami, Inc., Miami, Florida, 33014-3616, United States|Orlando Clinical Research Center, Orlando, Florida, 32809, United States|Prism Clinical Research, Saint Paul, Minnesota, 55114, United States|New Orleans Center for Clinical Research, Knoxville, Tennessee, 37920, United States|Auckland Clinical Studies Limited, Grafton, Auckland, 1010, New Zealand|Christchurch Clinical Studies Trust, Christchurch, 8011, New Zealand Less <<
NCT06629480 Antiretroviral Treatment|HIV I... More >>nfection|Metabolic Cardiovascular Syndrome Less << COMPLETED 2024-02-28 Hospital de Infectología, "... More >>;La Raza" National Medical Center, Mexico City, 02990, Mexico Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.13mL

2.23mL

1.11mL

22.25mL

4.45mL

2.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories